Blackmon Joseph A, Jeffy Brooke Grant, Malone Janine C, Knable Alfred L
Department of Internal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Arch Dermatol. 2011 Nov;147(11):1302-5. doi: 10.1001/archdermatol.2011.182. Epub 2011 Jul 18.
The primary hyperoxalurias are a group of rare autosomal recessive metabolic disorders associated with abnormal overproduction of serum oxalate and subsequent deposition in tissue. Most patients present at an early age with recurrent urolithiasis and renal failure. Vascular deposition of oxalate-producing skin manifestations, such as livedo reticularis, acrocyanosis, peripheral gangrene, and ulcerations, is typical of the primary hyperoxalurias.
We present the case of a 38-year-old woman with end-stage renal disease receiving hemodialysis with progressive skin changes, including livedo reticularis, superficial eschars, and brawny, woody fibrosis of her extremities, who was clinically suspected to have calciphylaxis or nephrogenic systemic fibrosis. Cutaneous biopsy specimens revealed rectangular, birefringent, yellowish-brown, polarizable crystalline material suggestive of oxalate within the dermis, subcutis, and medium-size vessels along with areas of focal epidermal and superficial dermal necrosis. Her subsequent medical history was obtained and was suggestive of a diagnosis of primary hyperoxaluria.
This case highlights the variability of clinical presentations in primary hyperoxaluria and that the disease can be diagnosed in adulthood. In addition, this case demonstrates that hyperoxaluria should be included in the differential diagnosis of calciphylaxis and nephrogenic systemic fibrosis.
原发性高草酸尿症是一组罕见的常染色体隐性代谢紊乱疾病,与血清草酸盐异常过量产生及随后在组织中的沉积有关。大多数患者在早年出现复发性尿路结石和肾衰竭。草酸盐在血管中的沉积导致皮肤表现,如网状青斑、手足发绀、外周坏疽和溃疡,是原发性高草酸尿症的典型症状。
我们报告了一例38岁终末期肾病接受血液透析的女性病例,其皮肤出现进行性变化,包括网状青斑、浅表焦痂以及四肢的硬结性、木样纤维化,临床怀疑为钙化防御或肾源性系统性纤维化。皮肤活检标本显示在真皮、皮下组织和中等大小血管内有长方形、双折射、黄棕色、可极化的结晶物质,提示为草酸盐,同时伴有局灶性表皮和浅表真皮坏死区域。随后了解到她的病史,提示原发性高草酸尿症的诊断。
该病例突出了原发性高草酸尿症临床表现的多样性,且该疾病可在成年期诊断。此外,该病例表明高草酸尿症应纳入钙化防御和肾源性系统性纤维化的鉴别诊断中。